Boc-L-aspartic acid β-cyclohexyl ester

Boc-L-aspartic acid β-cyclohexyl ester is a protected amino acid derivative in which L-aspartic acid is functionalized at the β-carboxyl position as a cyclohexyl ester while the α-amino group is protected with a Boc (tert-butoxycarbonyl) group. The molecule contains a free α-carboxylic acid group and a Boc-protected amino functionality, with the β-side chain bearing an esterified carboxyl that modulates hydrogen-bonding and provides a masked, non-zwitterionic handle relative to the free diacid. In peptide synthesis workflows, this protected β-ester form supports stepwise coupling by controlling chemoselectivity toward the α-carboxyl and Boc-protected amine, and it can serve as a precursor for generating aspartate-containing peptide fragments or as a chemically defined intermediate for aspartyl derivative preparation.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP00413

CAS No:73821-95-1

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.W/Mr.
315.4

Boc-L-aspartic acid β-cyclohexyl ester is a Boc-protected L-aspartic acid derivative in which the side-chain carboxyl group is esterified as a β-cyclohexyl ester, providing a protected, acid-stable handle for controlled peptide assembly. This protecting-group pattern is commonly selected to manage aspartate side-chain functionality during synthesis, enabling downstream deprotection and segment coupling without premature side-chain reactivity. The combination of an N-terminal Boc group with a β-cyclohexyl ester makes the material a practical building block for preparing aspartate-containing peptide intermediates and protected peptide segments.

1. Solid-Phase Peptide Synthesis

Boc-L-aspartic acid β-cyclohexyl ester is used as an aspartate building block for preparing protected peptide sequences where the side-chain carboxyl must remain masked during chain elongation. Peptide synthesis teams in custom peptide manufacturing and academic peptide chemistry commonly rely on this type of aspartate protection to reduce side reactions from the β-carboxyl group while maintaining a defined coupling site at the α-amino acid backbone. The Boc group supports established Boc-based peptide workflows, and the β-cyclohexyl ester provides a stable side-chain protection strategy that can be removed in a later step when the aspartate functionality is required for further coupling, purification, or final product generation.

2. Protected Aspartate Segment Building

Boc-L-aspartic acid β-cyclohexyl ester is frequently incorporated into protected aspartate-containing peptide segments for solution-phase assembly and segment condensation workflows. In peptide intermediate development, chemists value the ability to carry an aspartate side chain through multiple transformations while keeping the β-carboxyl protected as an ester, which helps maintain compatibility with coupling conditions used for neighboring residues. This approach supports the preparation of longer sequences by enabling selective deprotection timing, so that the aspartate side-chain can be revealed at a controlled stage for subsequent fragment coupling or final deprotection. The result is a robust intermediate suited for iterative peptide construction and library synthesis where aspartate integrity is critical.

3. Pharmaceutical Intermediate Development

Boc-L-aspartic acid β-cyclohexyl ester is used in the development of peptide-like or aspartate-containing intermediates that require controlled exposure of functional groups during downstream processing. Medicinal chemistry and process-development groups often select protected amino acid derivatives to streamline purification and to avoid undesired reactivity from free carboxylic acids during late-stage intermediate elaboration. The Boc-protected α-amino functionality and the β-cyclohexyl ester side-chain protection together provide a practical protection scheme for manufacturing workflows that depend on orthogonal timing of deprotection steps. This makes the derivative a relevant input for producing defined protected intermediates used in custom synthesis campaigns and scale-up-oriented intermediate preparation.

4. Aspartate-Rich Peptide Libraries

Boc-L-aspartic acid β-cyclohexyl ester supports the synthesis of aspartate-rich peptide libraries where maintaining side-chain protection consistency across many variants is essential for reproducible coupling and purification. Researchers building combinatorial or focused libraries in peptide discovery settings typically require a standardized aspartate building block that preserves the β-carboxyl as an ester throughout assembly, minimizing heterogeneity caused by partial side-chain deprotection. The Boc/β-cyclohexyl protection pattern facilitates controlled conversion from protected library members to later-stage functionalized peptides, enabling systematic evaluation of sequence-dependent properties while keeping the aspartate side chain protected during the library construction phase.

Abbr
Boc-Asp(OcHx)-OH

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicescGMP Peptide ServiceEpitope Mapping ServicesPeptide Modification ServicesPeptide Analysis ServicesPeptide Nucleic Acids SynthesisCustom Conjugation ServicePeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers